Open Access Research article

Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer

Nobumichi Tanaka*, Isao Asakawa, Kiyohide Fujimoto, Satoshi Anai, Akihide Hirayama, Masatoshi Hasegawa, Noboru Konishi and Yoshihiko Hirao

BMC Urology 2012, 12:28 doi:10.1186/1471-2490-12-28

Accesses  

  • Last 30 days: 69 accesses
  • Last 365 days: 785 accesses
  • All time: 785 accesses

Cited by

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations